Dr. Dannals is well-known for his pioneering research in the development of short-lived radiotracers for positron emission tomography and single photon emission-computed tomography.
He is a past president of the Society of Nuclear Imaging in Drug Development and a member of the Society of Nuclear Medicine and the American Chemical Society. He serves as the editor-in-chief of the Journal of Labeled Compounds and Radiopharmaceuticals and is a reviewer for several professional journals, including the Journal of Nuclear Medicine and the International Journal of Nuclear Medicine and Biology. Dr. Dannals is the author of more than 22 book chapters and 160 scientific papers.